Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-29

Clinical Trial Update: Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating photodynamic therapy with methyl-5-aminolevulinate hydrochloride cream to determine pain thresholds in patients with basal cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methyl-5-Aminolevulinate Hydrochloride Cream (methyl-5-aminolevulinate hydrochloride)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Basal Cell Carcinoma of the Skin, Pain | Phase 1 | Status: COMPLETED